MARILEE BAKER: Open Payments
NPI 1548856388 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,746 in 150 payments from 14 companies in 2025. Trend: 2023 $1,607 · 2024 $1,678 · 2025 $2,746
Food & beverage: $2,746
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 27 | $392 |
| ABBVIE INC. | 17 | $364 |
| Otsuka America Pharmaceutical, Inc. | 10 | $312 |
| Lundbeck LLC | 17 | $296 |
| Alkermes, Inc. | 14 | $282 |
| Neurocrine BioSciences, Inc. | 18 | $274 |
| Axsome Therapeutics, Inc. | 7 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $186 |
| Janssen Pharmaceuticals, Inc | 12 | $179 |
| Vanda Pharmaceuticals Inc. | 3 | $87 |
Products named: COBENFY, VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, Auvelity, ARISTADA, CAPLYTA, ABILIFY MAINTENA.
Industry payments across KY — which companies pay providers there.
